Cerebral blood flow (CBF) and rate of oxygen metabolism (CMRO 2 ) may be quantified using positron emission tomography (PET) with 15 O-tracers, but the conventional three-step technique requires a relatively long study period, attributed to the need for separate acquisition for each of 15 O 2 , H 2 15 O, and C 15 O tracers, which makes the multiple measurements at different physiologic conditions difficult. In this study, we present a novel, faster technique that provides a pixel-by-pixel calculation of CBF and CMRO 2 from a single PET acquisition with a sequential administration of 15 O 2 and H 2 15 O. Experiments were performed on six anesthetized monkeys to validate this technique. The global CBF, oxygen extraction fraction (OEF), and CMRO 2 obtained by the present technique at rest were not significantly different from those obtained with three-step method. The global OEF (gOEF) also agreed with that determined by simultaneous arterio-sinus blood sampling (gOEF AÀV ) for a physiologically wide range when changing the arterial PaCO 2 (gOEF ¼ 1.03gOEF AÀV þ 0.01, Po0.001). The regional values, as well as the image quality were identical between the present technique and three-step method for CBF, OEF, and CMRO 2 . In addition, a simulation study showed that error sensitivity of the present technique to delay or dispersion of the input function, and the error in the partition coefficient was equivalent to that observed for three-step method. Error sensitivity to cerebral blood volume (CBV) was also identical to that in the three-step and reasonably small, suggesting that a single CBV assessment is sufficient for repeated measures of CBF/CMRO 2 . These results show that this fast technique has an ability for accurate assessment of CBF/CMRO 2 and also allows multiple assessment at different physiologic conditions.
Introduction
Positron emission tomography (PET) allows the quantitative measurement of regional cerebral blood flow (CBF) and the rate of oxygen metabolism (CMRO 2 ), which has enabled us to understand the pathophysiologic basis of cerebrovascular disorders. These measurements are achieved using a protocol involving separate PET scans, one after the administration of each of three distinct 15 O-labeled radioactive tracers: H 2 15 O or C 15 O 2 for CBF, 15 O 2 for CMRO 2 , and C 15 O for cerebral blood volume (CBV) (Frackowiak et al, 1980a, b; Mintun et al, 1984; Lammertsma and Jones, 1983) . However, the complex nature of this procedure and its relatively long protocol often limit its applicability and also makes it difficult to perform at different physiologic conditions.
Quantitative images of CBF and CMRO 2 created with PET are calculated based on a single-tissue compartment model of oxygen and water kinetics (Frackowiak et al, 1980a, b; Mintun et al, 1984; Lammertsma and Jones, 1983) . The steady-state method (Subramanyam et al, 1978; Lammertsma et al, 1982; Correia et al, 1985; Okazawa et al, 2001a, b) has been used in a number of studies in which quantitative images are estimated from data acquired while in the steady state reached during continuous inhalation of C 15 O 2 and 15 O 2 . This method can be used using a simple procedure and mathematical formula, but still has several limitations. A prolonged data-acquisition period (approximately 1 h) is required, and the procedure is sensitive to error sources such as statistical noise and tissue heterogeneity (Lammertsma et al, 1982; Correia et al, 1985) . An additional drawback is the relatively high level of radiation exposure required to reach the steady state.
An alternative autoradiographic method (ARG) using only short administration times for each of the three tracers (three-step ARG) has been developed (Mintun et al, 1984) and subsequently simplified and optimized (Iida et al, 1993; Sadato et al, 1993; Hatazawa et al, 1995; Shidahara et al, 2002; Hattori et al, 2004) . Cerebral blood flow images can be obtained by an H 2 15 O autoradiographic method, using a PET counts-versus-CBF nomogram, which follows a simple look-up table procedure Herscovitch et al, 1983; Kanno et al, 1987) ; the quantitative accuracy of these images is improved when input delay and dispersion are corrected (Iida et al, 1986 (Iida et al, , 1988 . Rate of oxygen metabolism and the oxygen extraction fraction (OEF) can be estimated using data acquired during 15 O 2 inhalation, but must be corrected for clearance of radioactivity associated with CBF (Mintun et al, 1984) , CBV, and the level of recirculating radioactive water (Iida et al, 1993) . Although the total time required for three-step ARG is less than that of the steady-state method, it still requires at least half an hour, with a large part of this period spent waiting for radioactive decay between PET scans (more than 10 mins).
There have been other attempts to obtain CBF and CMRO 2 images more rapidly (Huang et al, 1986; Holden et al, 1988; Meyer et al, 1987; Ohta et al, 1992; Ho and Feng, 1999 ). Mathematical refinement has allowed images to be generated from data from a single scan alone on a bolus inhalation of 15 O 2 . The quality of the image suffers, however, from statistical noise because of the lack of predictability of the multiple parameters of CBF, CMRO 2 , and the arterial vascular compartment (V 0 ) and the limited acquisition time (Meyer et al, 1987; Ohta et al, 1992) . Therefore, this technique has not been generally applied in clinical settings, but has been used primarily for research purposes (Fujita et al, 1999; Vafaee and Gjedde, 2000; Okazawa et al, 2001a, b; Mintun et al, 2002) .
In this study, we have developed a novel, rapid PET technique called the dual-tracer ARG method (DARG) that involves a single session of PET scan during which two tracers of 15 O 2 and H 2 15 O are sequentially administered. This approach can shorten the total study period for the CBF and CMRO 2 measurement as compared with the three-step ARG, while maintaining the image quality and quantitative accuracy. A new formulation was derived so that the residual radioactivity of the first tracer is accounted for in the subsequent portion of the dynamic PET scan. We have then tested feasibility of this technique in an experiment on six anesthetized monkeys. A set of simulation was also performed to evaluate error sensitivity to possible error sources.
Materials and methods

Theory
The DARG protocol consists of a single dynamic PET scan conducted during the sequential administration of H 2 15 O and 15 O 2 in a short time interval. To calculate values of CBF, OEF, and CMRO 2 from these data, a new mathematical formula was derived based on a previously described single-tissue compartment model (Mintun et al, 1984 where A o (t) and A w (t) denote the arterial input function for oxygen and water in Bq/mL, f is CBF in mL 100/g min, E is the OEF, p is the blood/brain partition coefficient for water in mL/g, V B or V A is the total or arterial part of cerebral blood volume, respectively, R Hct is the small-to-large vessel hematocrit ratio, Fv is the effective venous fraction, and # indicates the convolution integral. Note that equation (1) describes the kinetics of radioactivity and is valid after the administration of either 15 O or H 2 15 O or after the administration of both. The first term on the right-hand side describes the amount of water entering the tissue, including both administrated and recirculating water. The second represents the amount of oxygen that enters the tissue and is immediately metabolized to water. The third and the fourth terms express the radioactivity of 15 O 2 and H 2 15 O in blood vessels, respectively. In the present study, we assumed that the last term is negligibly small compared with the radioactivity in tissue according to the previous study (Iida et al, 2000) . Then, we have
To produce pixel-by-pixel functional maps using a lookup table procedure, the formula was rearranged as follows. Equation (2) was integrated for the periods of H 2 15 O ( R w dt) and 15 O 2 administration (
In these equations, (4)) is represented by the first term on the right-hand side. Equation (4) can be rewritten as follows:
Substituting equation (5) into equation (3), we obtain Z W CiðtÞ dt ¼f
Using equation (6), f can be estimated using a look-up table procedure based on the observed PET data ( R w Ci(t)dt and R o Ci(t)dt, V B ) and the blood input functions (A o and A w ), as long as fixed values are assumed for P, Fv, and R Hct . Next, E can be calculated using equation(5). Rate of oxygen metabolism is then calculated from the estimated f and E, and the measured arterial oxygen content.
Positron Emission Tomography Experiments in an Animal System
We measured CBF and CMRO 2 using PET in six normal monkeys (Macaca fascicularis; body weight ¼ 5 kg) under stable anesthesia. The PET protocol for this study was designed to validate the global values of CBF (gCBF), CMRO 2 (gCMRO 2 ), and OEF (gOEF) generated using DARG by comparing them to those obtained using threestep ARG and the gOEF value measured by simultaneous arterial and cerebral sinus (A-V) blood sampling (gOEF AÀV ). In all six animals, we performed three- Risks, 1996) . The study protocol was approved by Subcomittee for Laboratory Animal Welfare, National Cardiovascular Center.
Anaesthesia was induced with ketamine (10 mg/kg, intramuscularly) and maintained by intravenous propofol Figure 2 Animal study protocol. After a 15-min transmission scan (TCT), a 6-min emission scan was performed after a 30-sec inhalation of C 15 O DARG was performed. To obtain an arterial time-activity curve, arterial blood was withdrawn continuously from the femoral artery through a catheter (0.6-mm inner diameter) using a syringe pump (Harvard Apparatus, model 55-2309) with a withdraw speed of 0.45 mL/min, and the whole-blood radioactivity concentration was measured using a GSO input function monitor system . We also measured the radioactivity concentration in plasma to estimate the 15 O-labeled water concentration produced as a metabolite of 15 O 2 , for which 0.2 mL of blood was centrifuged after manual sampling at eight time points: 30, 50, 70, 90, 110, 130, 160, and 190 secs after 15 O 2 inhalation. The radioactivity for plasma and whole blood was measured by a well counter (NaI(Tl) scintillation counter, Aloka, Japan) cross-calibrated to the PET scan, and expressed as Bq/mL.
Arterial-Sinus Blood Sampling
We performed arterial-sinus blood sampling to obtain a global OEF (gOEF A-V ) based on the Kety-Schmidt method (Kety and Schmidt, 1948) . The sinus blood was sampled through a 3F catheter, which was introduced via the femoral vein to the cerebral sinus using a high-resolution digital X-ray imaging system (GE Medical System, USA). To avoid mixing with venous blood draining from extracranial tissues, the tip of the catheter was carefully placed at the angle of the cerebral sigmoid and transverse sinuses, and its position was confirmed at the conclusion of each PET protocol. We sampled 0.2 mL of arterial and sinus blood simultaneously during each DARG PET scan and measured their oxygen content (C a O 2 and C v O 2 , respectively). The gOEF AÀV was calculated as follows:
Data Processing
Corrections for dead time, the radioactive decay, and normalization of detectors were performed using the sinogram-based method described previously O scan was summed for each period of labeled water (120 secs from the start time of water injection, or effectively 90 secs after the rise time of the tissue TAC), and oxygen intake (180 secs from the start time of oxygen inhalation). The summed images were corrected for attenuation using transmission data, and were reconstructed using the filtered-back-projection method with a 4-mm Gaussian filter. A reconstructed image consisted of a 128 Â 128 Â 47 matrix with a pixel size of 1.1 Â 1. O scans were reconstructed with same conditions as above and used for a nonlinear least-squares fitting (NLF) analysis.
To correct for the delay between the brain and blood TACs, the whole brain TAC was obtained from the corrected dynamic sinograms . The delay was estimated based on a method previously described (Iida et al, 1988) . Briefly, three parameters, K 1 , k 2 , and delay (Dt), were determined using whole brain and blood TACs around the period of H 2 15 O injection with an NLF procedure (Iida et al, 1988; Shidahara et al, 2002) . The dispersion time constant was fixed at 3 secs .
To compute CBF, OEF, and CMRO 2 as described above, it is necessary to obtain separated 15 O 2 and H 2 15 O input functions (A o and A w ) from the measured arterial TAC, because the arterial blood TAC measured during the second phase of the scan reflects not only the radioactivity of the second tracer but also the residual activity of the first. For the H 2 15 O- 15 O 2 protocol, we first estimated the TAC for the residual radioactivity from the first tracer (H 2 15 O) administration remaining during the second period by extrapolating the arterial TAC of the first phase by a model of input function . We then subtracted it from the measured total arterial TAC in the second phase to obtain a TAC for the second tracer. Second, the metabolic product (recirculating water) following 15 O 2 administration was estimated using the plasma radioactivity measured during the phase of 15 O 2 and a fitting procedure described previously (Huang et al, 1991; Iida et al, 1993 15 O 2 TAC from the first phase as described above, and then obtained A o and A w . The preliminary validation of this procedure is described elsewhere .
The C 15 O sinogram data summed over 240 secs beginning at 120 secs after C 15 O inhalation, and reconstructed. The CBV images were then generated from the C 15 O images using the blood radioactivity concentration averaged over the scan period, with an assumption of a peripheral-to-central hematocrit ratio (R Hct ) of 0.85 (Phelps et al, 1979) , a blood density of 1.06 g/mL, and a brain-tissue density of 1.04 g/mL (Lammertsma et al, 1987) .
A set of CBF, OEF, and CMRO 2 images were calculated according to the DARG technique, using a set of integrated images (
, and TACs for H 2 15 O (A w ) and 15 O 2 (A o ) based on the formula described above, assuming P ¼ 0.8 mL/g (Iida et al, 1991) and Fv ¼ 0.835 (Mintun et al, 1984) . Corresponding images were also calculated according to the three-step ARG using a procedure previously described . Briefly, the CBF image was calculated using the reconstructed image for H Rapid quantitative measurement of CMRO 2 and CBF N Kudomi et al 50 mm in size). Regression analysis was performed comparing the values of CBF and CMRO 2 between three-step ARG and either DARG sequence. To test the validity of using a fixed p in the DARG protocol, regional CBF, OEF, and CMRO 2 values were also calculated using the NLF technique. Using a GaussianNewton algorithm, three parameters of f, E, and p were fitted to equation (2) using arterial input functions for H 2 O and O 2 , as determined previously. The CBV was fixed at each ROI using the C 15 O scan value, and all other parameters were fixed at the same values as described above. Tissue TACs for each region were extracted by averaging four TACs in frontal regions, six in temporal regions, four in parietal regions, four in occipital cortical regions, and six in subcortical ROI; those ROIs were projected to the dynamic PET images for H 2 O-O 2 and O 2 H 2 O. In each region, CBF, OEF, and CMRO 2 values were computed by NLF and DARG and compared using a paired t-test. All data are presented as means7s.d., and Po0.05 was considered statistically significant.
Error Analyses in Simulation
Error propagation was analyzed for four factors: delay and dispersion in arterial TAC, blood/tissue partition coefficient (P), and cerebral blood volume (V B ). It is known that the measured arterial TAC is delayed and more dispersed relative to the true input TAC in the brain because of the time it takes for blood to traverse the peripheral artery and catheter tube before reaching the detector (Iida et al, 1986 (Iida et al, , 1988 (Iida et al, , 1989 (Iida et al, , 2000 Lammertsma et al, 1990 ). Calculation of CBF using ARG PET always uses a fixed partition coefficient throughout the whole brain (ranging 0.8 to 0.9 mL/g) and does not evaluate it regionally (Herscovitch and Raichle, 1985; Iida et al, 1989 Iida et al, , 1991 Shidahara et al, 2002 ). An error in CBV measured by the PET scan may also introduce errors in calculating the cerebral oxygen consumption (Mintun et al, 1984; Lammertsma et al, 1987) .
Typical arterial input functions for water (A w ) and oxygen (A o ) were obtained from one monkey in this study and used after simulation as the true arterial TACs. Using these arterial TACs and equation (2), tissue TACs for water Figure 7 Error propagation from the error in input delay time to the functional parameters: (A) CBF, (B) OEF, and (C) CMRO 2 . Positive and negative values of error in delay time indicate over-and undercorrection of delay time, respectively, whereas zero (secs) in the transverse axis corresponds to when the delay of measured artery input was accurately corrected to the true cerebral arterial input. Three-step ARG, conventional three- Rapid quantitative measurement of CMRO 2 and CBF N Kudomi et al and oxygen were created using known values for normal brain tissue (CBF ¼ 50 mL 100/g min, OEF ¼ 0.4, CBV ¼ 0.04 mL/g, P ¼ 0.8 mL/g, Fv ¼ 0.835, and R Hct ¼ 0.85). These TACs were used as true tissue TACs for three-step ARG. True tissue TACs for DARG were created by adding two tissue TACs for each tracer with a time lag of 3 mins, simulating the interval of administration. To simulate the error propagation resulting from errors in estimated delay time and dispersion time constants, the error in delay time or dispersion time was varied from À4 to 4 secs, where a positive error represents an overcorrection of delay time or dispersion time constant, and a negative error represents undercorrection, as described previously (Iida et al, 2000) . Values for CBF, OEF, and CMRO 2 were calculated based on three-step ARG and DARG. To shift the dispersion time constants, the true arterial TAC was convoluted or deconvoluted with a simple exponential (Iida et al, 1986; Kanno et al, 1987) . For simulating the error in the values of p and V B , the value of p was varied from 0.7 to 0.9 mL/g, and that of V B from 0.02 to 0.06 mL/g; in each situation, tissue TACs were created and CBF, OEF, and CMRO 2 values were calculated using these TACs, assuming P ¼ 0.8 mL/g and V B ¼ 0.04 mL/g. Errors in these calculated values are presented as percentage differences from the normal values for each DARG and three-step ARG. In DARG, both orders of tracer administration were simulated. Figure 3 shows an example of measured and estimated blood TACs (A o and A w ) and whole brain TAC in one 15 Figure 5 . The obtained regression lines for CBF were CBF (DARG (H 2 O-O 2 )) ¼ CBF (three-step) þ 0.00 mL 100/g/min (r ¼ 1) and CBF (DARG (O 2 -H 2 O)) ¼ 1.03 CBF (three-step) þ 0.75 mL 100/g/min (r ¼ 0.88). For CMRO 2 , the regression lines were CMRO 2 (DARG (H 2 O-O 2 )) ¼ 0.97 CMRO 2 (three-step) þ 0.00 mL 100/g/ min (r ¼ 0.91) and CMRO 2 (DARG (O 2 -H 2 O)) ¼ 1.09 CMRO 2 (three-step)À0.11 mL 100/g/min (r ¼ 0.93), and showed that the values of slope were not significantly different from the unity.
Results
Animal Experiments
In Table 2 , values of CBF, OEF, and CMRO 2 in regional ROI computed by DARG and NLF are listed for each data set for both 15 In each region, the estimated value of p for NLF was not different from the assumed value of 0.8 (one Figure 9 Error propagation from the partition coefficient to the functional parameters: (A) CBF, (B) OEF, and (C) CMRO 2 . When the true p (transverse line) changed from 0.7 to 0.9 mL g À1 , the size of the error in each variable calculated, assuming p ¼ 0. Rapid quantitative measurement of CMRO 2 and CBF N Kudomi et al sample t-test, P40.05); however, two-way analysis of variance with 'region' and 'subject' as factors showed a statistically significant effect of 'region' on p (F 4, 30 ¼ 5.27, P ¼ 0.029). Its mean was the smallest in the subcortex (0.69 to 0.70 mL/g). Considering that subcortical ROI size involves not only white matter but also subcortical gray matter and ventricles, this result supports a previous notion that tissue mixtures cause an underestimation of p (Iida et al, 1989) . Therefore, these results suggest that using a fixed p value seems not to cause significant bias in CBF, OEF, and CMRO 2 . Figure 6 provides a representative set of CBF, OEF, and CMRO 2 images generated by DARG and threestep ARG. The functional images generated from DARG were of comparable quality to those obtained using three-step ARG.
Error Analysis
Effects of delay correction errors: (Figure 7) O was almost equal to the value for threestep ARG. For example, when the error in the measured delay was 2 secs, errors in DARG were at most 5%, 3%, and 3% in CBF, OEF, and CMRO 2 , respectively. Considering that the error estimation of delay would be up to 2 secs in the present procedure (Kanno et al, 1987; Shidahara et al, 2002) , these results indicate that the error sensitivity to delay associated with DARG did not greatly exceed that from three-step ARG.
Effects of dispersion correction errors (Figure 8) O was nearly equal to that of threestep ARG. The magnitude of errors introduced in CBF, OEF, and CMRO 2 were less than 5% for all estimation procedures even if there was 2 secs of error in estimating the time constant of dispersion (Iida et al, 1986) . These results also indicate that the error sensitivity to dispersion in DARG does not significantly exceed that associated with three-step ARG.
Effects of the partition coefficient (Figure 9) 15 O 2 for OEF and CMRO 2 were somewhat larger than those associated with three-step ARG, the overall error sensitivity in DARG was similar to that in three-step ARG.
Effects of blood volume (Figure 10 ): The error sensitivities in both DARG experiments were identical to those obtained from three-step ARG. The magnitude of error introduced into the CBF estimate were less than 1%, and that for OEF and CMRO 2 was less than 5% in all methods, even assuming a true CBV of 0.06 mL/g. This simulation study shows that the error sensitivity introduced in the quantitative values of CBF, OEF, and CMRO 2 for the first phase of the dynamic PET scan used in DARG was nearly the same as that in three-step ARG. In contrast, the error for the second phase was either enhanced or suppressed, depending on the relationship of the error between measured or assumed parameters and the estimate of residual radioactivity.
Finally, we have estimated the sensitivity in diseased tissue that simulates decreased CBF with elevated OEF (f ¼ 20 mL 100/g min and E ¼ 0.7), namely the ischemic lesion. The magnitude of error in the functional values of this tissue was roughly the same in terms of delay and dispersion, and was relatively smaller in terms of p and CBV, than the magnitude of error for assumed normal tissue. For example, when assumed 5% error in P, the magnitude of error introduced in CBF, OEF and CMRO 2 
Discussion
In this study, we have proposed a novel, rapid PET technique for quantitative assessment of both CBF and CMRO 2 from a single PET scanning with sequential administration of two tracers. This article described the validity of this technique in anesthetized monkeys at rest and during varied PaCO 2 conditions. There was no significant difference in CBF, OEF, or CMRO 2 values at rest, as compared with those obtained using three-step ARG. The estimated OEF values were also found to be in a good agreement with those derived from arteriosinus blood sampling for a wide physiologic range. The image quality generated by DARG was identical to that of three-step ARG. The simulation also showed that the errors in the estimated parameters attributed to errors in delay, dispersion and the assumed partition coefficient was in the same level as compared with that of the three-step ARG. It should also be noted that the error sensitivity to the CBV was reasonably small, namely almost no errors in CBF, and only 75% errors in OEF and CMRO 2 are caused even if 750% errors are included in CBV. These findings suggest that the DARG technique provides CBF and CMRO 2 images with reasonable accuracy and quality, and also allows multiple assessment of CBF/CMRO 2 , provided that a single CBV scan is performed.
The (Koeppe et al, 2001) . Another application of this approach is the repeat assessment of CBF. Watabe et al (2002) showed that CBF images can be quantitated at much shorter interval than the previous protocol, typically at 90 secs, from sequential PET scanning Altman et al (1991) obtained OEF values of 0.5370.13 from arteriosinus blood sampling. Using steady-state PET, others have measured OEFs ranging from 0.42 to 0.58 in normal tissues of anesthetized monkeys (Altman et al, 1991; Pappata et al, 1993; Touzani et al, 1995; Young et al, 1996; Schumann et al, 1996; Frykholm et al, 2000) . Moreover, the values of gCBF in the present PET study were 3079 mL 100/g min from three-step ARG, 3079 mL 100/g min from Previously reported values varied from 27 to 37 mL 100/g min for CBF and 2.4 to 3.4 mL 100/g min for CMRO 2 (Altman et al, 1991; Pappata et al, 1993; Touzani et al, 1995; Young et al, 1996; Schumann et al, 1996; Frykholm et al, 2000) . Variations are because of the differences in monkey species, physiologic conditions, anesthetic agent used, PET scanner, and methodology; the current results clearly show that the DARG method can be used to determine these physiologic parameters with a high degree of accuracy.
There has not been systematic error sensitivity analysis for the conventional three-step ARG method. We thus have performed a simulation study to evaluate the error sensitivity for both the three-step ARG and DARG techniques. The error sensitivity appeared to be almost identical for all error sources estimated in the simulation. Small differences were, however, seen in particular cases obtained in this experiment. These differences may have arisen because of incorrect estimation of residual radioactivity in the second phase of the PET data. For example, when the true p is larger than the value assumed for H 2 15 O-15 O 2 , the CBF will be estimated as larger than the true value. Thus, washout of water will be overestimated, leading to a lower estimate of residual radioactivity. Underestimation of the residual radioactivity and large p values results in an overestimation of oxygen uptake (OEF), thus increasing the error in the CMRO 2 value. It is also notable that when the delay was overcorrected in H 2 15 O-15 O 2 , the error in CMRO 2 decreases compared with three-step ARG. The CBF becomes smaller than the true value and the amount of residual radioactivity will also be estimated to be smaller, causing overestimation of oxygen uptake (OEF). As a result, similar magnitudes of overestimation of OEF and underestimation of CBF will cancel the error in CMRO 2 .
The present model provides pixel-by-pixel estimates of CBF, CMRO 2 , and OEF based on data from a single PET scan, assuming a constant partition coefficient (p) for H 2 15 O, as has been perfprmed for H 2 15 O autoradiography Raichle et al, 1983) and the three-step method (Mintun et al, 1984) . The error in p propagates not only to CBF but also to OEF and CMRO 2 . We used a fixed value of 0.8 mL/g for p, which was empirically determined so as to minimize the tissue mixture associated with the limited spatial resolution of PET scanner (Iida et al, 1989 (Iida et al, , 1991 . The simulation study showed that the range of errors was almost within an acceptable range. Regional analysis also showed that the CBF, OEF, and CMRO 2 values provided by DARG were consistent with by NLF in normal monkeys. Thus, using a fixed p value in DARG should not cause significant bias provided that CBF, OEF, and CMRO 2 are of interest. However, this should be further validated in humans, as the effective p value could be affected by the tissue mixture and the magnitude of this effect might be different in human (Iida et al, 1991) .
Several previous studies showed the feasibility of fixing a p value for H 2 15 O ARG (Herscovitch and Raichle, 1985; Kanno et al, 1987; Iida et al, 1989) and the three-step ARG (Mintun et al, 1984; Iida et al, 1993) . One may argue the adequacy of this assumption in diseased tissues, that is, the p values may be increased in edematous regions, or decreased in the area of necrotic tissue. In case CBF is reduced in such lesions, errors in the estimated parameters would be small, because a linear relationship is expected between the tissue-radioactivity counts and the physiologic parameters, and the p does not contribute significantly to the kinetic behavior of the tracer accumulation. However, a great error can be expected if CBF is at a high range in the area of reduced p, as only a small change in p may cause large changes in the tissue accumulation of the tracers. Exact magnitude is unknown, and should be evaluated carefully for each of diseased conditions.
The present method has several advantages over three-step ARG. It eliminates the time required for radioactive decay between the H 2 15 O and 15 O 2 scans, thus shortening the procedure by at least 10 mins compared with the three-step method. Importantly, it also minimizes the error resulting from physiologic fluctuations. Kinetic models of CBF-CMRO 2 used in PET techniques assume constant physiologic conditions throughout all PET scans, and CMRO 2 is mathematically dependent on CBF. Thus, physiologic changes during PET measurement may underlie in part the errors in quantitative values. It is well known that CBF easily varies with PaCO 2 (Grubb et al, 1974) and PaO 2 (Borgstrom et al, 1975; Johannsson and Siesjo, 1975) ; however, CMRO 2 remains constant. In fact, Hattori et al (2004) recently showed that OEF values in three-step method were not identical to those in gOEF AÀV in human, suggesting the presence of physiologic change during the measurement. The present method may also make physiologic interpretations of flow and metabolism more accurate (Hayashi et al, 2003) . Finally, it allows evaluation of coupling or uncoupling of CBF and CMRO 2 during functional activation or pharmacological stress, such as that induced by acetazolamide used for assessment of cerebral vascular reserves. Ohta et al (1992) showed another technique for the rapid estimation of CBF, OEF, and CMRO 2 from a 3-min single PET scan following bolus inhalation of 15 O 2 . This approach does not take into account recirculating water and involves a mathematical formula with weighted integration to calculate these quantitative values. However, the generated functional images suffer from statistical noise, which is attributed to the need for determination of multiple Rapid quantitative measurement of CMRO 2 and CBF N Kudomi et al parameters from a small amount of time-varying data. Cerebral blood flow images, in particular, suffer significantly from noise; precise determination of CBF often requires another PET scan with H 2 15 O injection (Meyer et al, 1987; Ohta et al, 1999; Fujita et al, 1999; Mintun et al, 2002) . In contrast, the present approach can generate images of reasonable quality from a single 6-min PET scan. Although currently it still requires another C 15 O scan for CBV correction, we believe that an additional mathematical formulation strategy, such as the basis function method (Gunn et al, 1997) could eliminate this need. In addition, to shorten the time for the transmission scan, we could possibly apply a segmented attenuation correction technique (Xu et al, 1994 (Xu et al, , 1996 . We believe that the total PET scan time for measuring CBF and CMRO 2 , for which patients need to be on the bed of the PET scanner, could be minimized to around 10 mins.
In the present study, the recirculating water in the arterial blood has been measured directly and continuously from separated plasma. This is laborious and may limit the use of this protocol for clinical studies. However, Iida et al (1993) have estimated the amount of recirculating water and showed that its amount can be predicted using a single compartment model in three-step ARG in normal human subjects. This method eliminates the need for plasma separation and simplifies the PET procedure (Hatazawa et al, 1995; Shidahara et al, 2002) . However, as this method depends on intersubject variation of the arterial 15 O 2 TAC (which yields a bias in the CMRO 2 in DARG), its validity requires further evaluation in human studies.
Although the present study provided images of relatively good quality, image quality depends on many different factors, such as the interval, (relative) dose, and order of the two administered tracers. Given a shorter interval time between tracer administrations, a larger amount of residual radioactivity from the first tracer remains during the image acquisition for the second tracer, degrading the quality of the image calculated during the second phase of the procedure. We fixed the time interval to 3 mins in the present study based on preliminary simulations , which suggested that images of an equivalent quality to three-step ARG could be obtained if the time interval was at least 3 mins. The deteriorated image quality because of the second tracer can be compensated for if the amount of the second tracer is increased, so long as there are no mitigating factors such as scatter, random coincidence, and event loss because of dead time. The effects on image quality resulting from the alteration of dosage parameters are complex, and parameter changes may interact in ways that interfere with each other. From a practical point of view, the reliability of specific parameters may be limited by properties of each tracer that depend on the labelling efficiency of H 2 15 O synthesis, and can differ between supply facilities, as well as the distance and flow rate from the synthesizer to the PET scanner. Further studies are required to optimize these parameters to maximize image quality when applying this method to human studies.
In conclusion, although several issues remain to be investigated, this study shows the feasibility of rapid and simultaneous measurement of CBF and CMRO 2 using a single PET scan and the sequential administration of two tracers. Both experimental and simulation studies show that the DARG method provides reasonable accuracy for quantitative values of CBF, OEF, and CMRO 2 , and that the quality of the images produced was comparable to that of threestep ARG. The present study suggests that this method may be applicable to the estimation of CBF and CMRO 2 in humans, particularly in acute to subacute ischemic patients or in the multiple assessment of CBF/CMRO 2 at different physiologic conditions.
